Literature DB >> 9382970

Bacterial meningitis in cirrhosis: review of 16 cases.

A Pauwels1, E Pinès, M Abboura, I Chiche, V G Lévy.   

Abstract

BACKGROUND: Although bacterial infections are frequent in patients with liver cirrhosis, only isolated cases of bacterial meningitis have been reported.
METHODS: We have reviewed a series of 16 cases of bacterial meningitis in patients with cirrhosis, diagnosed in a single hospital over a 30-year period.
RESULTS: Thirteen patients had alcoholic cirrhosis. On presentation, all patients had fever and most of them had an abnormal mental status (coma in 11 cases), but neck stiffness was not present or was delayed for more than 24 h in seven (43.7%) patients. The cerebrospinal fluid white cell count was always elevated, higher than 1000/microl in ten cases. The cerebrospinal fluid culture was positive in 14 (87.5%) patients. Gram-negative bacilli (mainly E. coli) and L. monocytogenes were the most frequent pathogens, accounting for nine cases. In contrast, S. pneumoniae and N. meningitidis were found in only four cases. Concurrent bacteremia was present in 12 (75%) cases. Ten patients (62.5%) died. Death was meningitis-related in seven patients and due to decompensated liver cirrhosis after clinical recovery from meningitis in the three other patients. Child-Pugh class C was associated with a higher mortality rate (80%, versus 33% for Child-Pugh class A-B), although the difference did not reach statistical significance.
CONCLUSIONS: Bacterial meningitis should be suspected in every patient with cirrhosis presenting with a febrile coma. If lumbar puncture must be delayed, or if no causative agent can be identified on cerebrospinal Gram stain despite elevated cerebrospinal fluid white cell count, empirical antimicrobial therapy should be started straightaway with ampicillin plus a third-generation cephalosporin in sufficient doses.

Entities:  

Mesh:

Year:  1997        PMID: 9382970     DOI: 10.1016/s0168-8278(97)80320-0

Source DB:  PubMed          Journal:  J Hepatol        ISSN: 0168-8278            Impact factor:   25.083


  9 in total

1.  Community-acquired spontaneous Klebsiella pneumoniae meningitis in adult cirrhotic patients with and without diabetes.

Authors:  W N Chang; C H Lu; J J Wu; C B Lei; C R Huang
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2003-03-22       Impact factor: 3.267

2.  Bacterial infections other than spontaneous bacterial peritonitis in cirrhosis.

Authors:  Chalermrat Bunchorntavakul; Disaya Chavalitdhamrong
Journal:  World J Hepatol       Date:  2012-05-27

3.  Extraintestinal pathogenic Escherichia coli as a cause of invasive nonurinary infections.

Authors:  James R Johnson; Abby Gajewski; Alan J Lesse; Thomas A Russo
Journal:  J Clin Microbiol       Date:  2003-12       Impact factor: 5.948

Review 4.  Risk factors and outcome of bacterial infections in cirrhosis.

Authors:  Tony Bruns; Henning W Zimmermann; Andreas Stallmach
Journal:  World J Gastroenterol       Date:  2014-03-14       Impact factor: 5.742

5.  Prevention and management of bacterial infections in cirrhosis.

Authors:  Sunil K Taneja; Radha K Dhiman
Journal:  Int J Hepatol       Date:  2011-08-28

6.  Spontaneous Escherichia coli Meningitis and Brain Abscess in an Immunocompetent Adult.

Authors:  Keesha Jeter; Arun Dang; Aaron Ly; Deepthi Jayasekara
Journal:  Cureus       Date:  2022-09-03

7.  Klebsiella pneumoniae septic arthritis in a cirrhotic patient with hepatocellular carcinoma.

Authors:  Chang Hwan Park; Young Eun Joo; Sung Kyu Choi; Jong Sun Rew; Sei Jong Kim
Journal:  J Korean Med Sci       Date:  2004-08       Impact factor: 2.153

8.  Community-acquired bacterial meningitis in alcoholic patients.

Authors:  Martijn Weisfelt; Jan de Gans; Arie van der Ende; Diederik van de Beek
Journal:  PLoS One       Date:  2010-02-08       Impact factor: 3.240

Review 9.  Life-threatening infections in medically immunocompromised patients.

Authors:  Hasan M Al-Dorzi; Raymond Khan; Yaseen M Arabi
Journal:  Crit Care Clin       Date:  2013-08-12       Impact factor: 3.598

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.